# Safety and Tolerability of the Ophthalmic Solution PRO-156 in Ophthalmologically Healthy Volunteers.

> **NCT01871077** · PHASE1 · COMPLETED · sponsor: **Laboratorios Sophia S.A de C.V.** · enrollment: 30 (actual)

## Conditions studied

- Healthy

## Interventions

- **DRUG:** PRO-156

## Key facts

- **NCT ID:** NCT01871077
- **Lead sponsor:** Laboratorios Sophia S.A de C.V.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2013-09
- **Primary completion:** 2013-12
- **Final completion:** 2013-12
- **Target enrollment:** 30 (ACTUAL)
- **Last updated:** 2019-10-25


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01871077

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01871077, "Safety and Tolerability of the Ophthalmic Solution PRO-156 in Ophthalmologically Healthy Volunteers.". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT01871077. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*